All posts by: Michael Zand

About Michael Zand

BioTech Holdings Announces First Clinical Use of Microbiome Optimized Autologous Stem Cells – PR Newswire (press release)

Continue reading

2017-07-07 NEWS

BioTech Holdings Announces First Clinical Use of Microbiome Optimized Autologous Stem Cells
PR Newswire (press release)
SAN DIEGO, July 7, 2017 /PRNewswire/ — BioTech Holdings announced today clinical safety data on 3 patients suffering from critical limb ischemia treated with the Company’s Procell microbiome-optimized personalized stem cell product. In the

Continue reading

2017-07-07 NEWS

Healthcare Global

Consider risks of unapproved stem cell treatment
Kamloops This Week
As the KTW article noted, the federal government committed $20 million to the Centre for Commercialization of Regenerative Medicine in 2016, but it wasn’t to establish a “stemcell therapy development facility in Toronto.” Rather, the funding is to
The rise of medical tourism is impacting stem cell treatmentsHealthcare Global

all 2 news articles »

Continue reading

2017-07-07 NEWS

Greater understanding of plant hormone results in stem cells that grow shoots
Science Daily
The result confirms understanding of how to establish stem cells that lead to different types of organ growth. “What we have done is activate the plant to make a stem cell center for a shoot to form,” said Schaller. “By finding the direct targets of

Continue reading

2017-07-07 NEWS

Make it a Double: Immunotherapy Combinations for Advanced Melanoma
Curetoday.com
Make it a Double: Immunotherapy Combinations for Advanced Melanoma. Increasingly, immunotherapy drugs for advanced melanoma are being studied in combination. PUBLISHED: JULY 07, 2017. Be the first to discuss this article on CURE’s forum. >>.

and more »